Biogen Inc. buy The Goldman Sachs Group, Inc.
Start price
13.02.25
/
50%
€132.80
Target price
13.02.26
€234.78
Performance (%)
24.13%
End price
14.02.26
€164.85
Summary
This prediction ended on 14.02.26 with a price of €164.85. The prediction had a final performance of 24.13%. The_Goldman_Sachs_Gr has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 3.348% | 3.348% | 28.163% |
| iShares Core DAX® | -1,66 % | -10,87 % | -0,72 % |
| iShares Nasdaq 100 | -3,77 % | -5,15 % | 13,41 % |
| iShares Nikkei 225® | -2,80 % | -11,30 % | 25,46 % |
| iShares S&P 500 | -2,30 % | -4,80 % | 8,94 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $281.00 to $245.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten